Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Hasan Al-Sayegh"'
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 7, Iss 4, Pp n/a-n/a (2024)
ABSTRACT Objectives To determine the incidence, presentation, frequency and management of immune checkpoint inhibitors (ICI)‐related endocrinopathies in a comprehensive cancer centre in Oman, particularly with programme death 1/programme death‐li
Externí odkaz:
https://doaj.org/article/31a18349021b4b6ea62cbafa501cb426
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEPrevious studies have reported that cancer incidence trends in Oman varied by tumor site and sex. No comprehensive analysis of all cancer sites had been reported. The objective of this study is to analyze cancer incidence trends in Oman and ca
Externí odkaz:
https://doaj.org/article/29b92c1b2baa4f7b94a7326100091d67
Autor:
David S. Shulman, Lulla V. Kiwinda, Stacey Edwards, Catherine M. Clinton, Sarah Hunt, Lianne Greenspan, Kristen D. Lawler, Gregory Reaman, Hasan Al‐Sayegh, Kira Bona, Allison F. O'Neill, Suzanne Shusterman, Katherine A. Janeway, Andrew E. Place, Susan N. Chi, Clement Ma, Steven G. DuBois
Publikováno v:
Cancer Medicine, Vol 10, Iss 7, Pp 2310-2318 (2021)
Abstract Background Single patient Investigational New Drug (IND) applications are one mechanism through which experimental therapies are accessed for children with cancer. The landscape of use, outcomes, and toxicity from single patient INDs remains
Externí odkaz:
https://doaj.org/article/a55985f140e94952817cff413dfa8e6f
Autor:
Mir Lim, David S. Shulman, Holly Roberts, Anran Li, Jessica Clymer, Kira Bona, Hasan Al‐Sayegh, Clement Ma, Steven G. DuBois
Publikováno v:
Cancer Medicine, Vol 9, Iss 18, Pp 6658-6666 (2020)
Abstract Background Off‐label drug prescribing is common in pediatric clinical medicine, though the extent and impact of this practice in pediatric oncology has not yet been characterized. Methods We completed a retrospective single‐institution c
Externí odkaz:
https://doaj.org/article/c0eaf4ca092c4d2a8f696014a5e2ee83
Autor:
Eduard J. van Beers, Stephanie van Straaten, D. Holmes Morton, Wilma Barcellini, Stefan W. Eber, Bertil Glader, Hassan M. Yaish, Satheesh Chonat, Janet L. Kwiatkowski, Jennifer A. Rothman, Mukta Sharma, Ellis J. Neufeld, Sujit Sheth, Jenny M. Despotovic, Nina Kollmar, Dagmar Pospíšilová, Christine M. Knoll, Kevin Kuo, Yves D. Pastore, Alexis A. Thompson, Peter E. Newburger, Yaddanapudi Ravindranath, Winfred C. Wang, Marcin W. Wlodarski, Heng Wang, Susanne Holzhauer, Vicky R. Breakey, Madeleine Verhovsek, Joachim Kunz, Melissa A. McNaull, Melissa J. Rose, Heather A. Bradeen, Kathryn Addonizio, Anran Li, Hasan Al-Sayegh, Wendy B. London, Rachael F. Grace
Publikováno v:
Haematologica, Vol 104, Iss 2 (2019)
Externí odkaz:
https://doaj.org/article/7c186564490a4bcea73e25b735945c6c
Autor:
Clement Ma, Katherine A. Janeway, David S. Shulman, Stacey Edwards, Catherine Clinton, Gregory H. Reaman, Steven G. DuBois, Suzanne Shusterman, Hasan Al-Sayegh, Kira Bona, Andrew E. Place, Lianne Greenspan, Sarah K. Hunt, Kristen Lawler, Allison F. O'Neill, Lulla V Kiwinda, Susan N. Chi
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 7, Pp 2310-2318 (2021)
Cancer Medicine, Vol 10, Iss 7, Pp 2310-2318 (2021)
Background Single patient Investigational New Drug (IND) applications are one mechanism through which experimental therapies are accessed for children with cancer. The landscape of use, outcomes, and toxicity from single patient INDs remains unknown
Autor:
Steven G. DuBois, Mir Lim, Holly Roberts, Anran Li, Clement Ma, Jessica Clymer, Kira Bona, Hasan Al-Sayegh, David S. Shulman
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 18, Pp 6658-6666 (2020)
Cancer Medicine, Vol 9, Iss 18, Pp 6658-6666 (2020)
Background Off‐label drug prescribing is common in pediatric clinical medicine, though the extent and impact of this practice in pediatric oncology has not yet been characterized. Methods We completed a retrospective single‐institution cohort stu
Autor:
Ashley S. Plant‐Fox, Clement Ma, Hasan Al‐Sayegh, Derek Shyr, Michelle A. Lee, Leslie E. Lehmann, Susan N. Chi
Publikováno v:
Pediatric Transplantation. 26
Medulloblastoma outcomes have improved with craniospinal irradiation and chemotherapy, but such therapy has resulted in poor neurocognitive outcomes for young patients. Chemotherapy-only regimens with autologous transplant have been implemented with
Publikováno v:
Pediatr Blood Cancer
BACKGROUND Many childhood cancersurvivors experience at least one late effect of treatment, and both late effects and persistent cancer-related worry can negatively impact quality of life in survivorship. Little is known about the prevalence or impac
Autor:
Ellis J. Neufeld, Rachael F. Grace, Satheesh Chonat, Heather A. Bradeen, Vicky R. Breakey, Heng Wang, Stefan W. Eber, Susanne Holzhauer, Bertil Glader, Nina Kollmar, Hassan M. Yaish, Hasan Al-Sayegh, Sujit Sheth, D. Holmes Morton, Jennifer A. Rothman, Wendy B. London, Yaddanapudi Ravindranath, Mukta Sharma
Publikováno v:
Pediatric bloodcancerREFERENCES. 68(9)
Pyruvate kinase deficiency (PKD) is a rare, autosomal recessive red blood cell enzyme disorder, which leads to lifelong hemolytic anemia and associated complications from the disease and its management.An international, multicenter registry enrolled